Concord Biotech lists with 21% premium on the BSE

18 Aug 2023 Evaluate

Concord Biotech has debuted at Rs 900.05 on the BSE, up by 159.05 points or 21.46% from its issue price of Rs 741.

The scrip is currently trading at Rs 937.00, up by 196.00 points or 26.45% from its issue price. It has touched a high and low of Rs 987.05 and Rs 900.00 respectively. So far 12.88 lakh shares were traded on the counter.

The offering, which was open for subscription between August 4, 2023 and August 8, 2023 was subscribed 24.87 times. The issue price was fixed at Rs 741 per share i.e. at upper end of price band of Rs 705-741 apiece.

Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs, focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial. It has three manufacturing facilities at Valthera, Dholka, and Limbasi, in Gujarat.


Concord Biotech Share Price

1404.05 1.00 (0.07%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×